Summary Semaglutide is a powerful medication that offers promising results in weight loss
In cases where skin reactions significantly impact quality of life or suggest hypersensitivity, your provider will assess whether continuing tirzepatide remains appropriate or whether alternative diabetes or weight management therapies should be considered
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
GLP-1 Analog liraglutide improves vascular function in polymicrobial sepsis by reduction of oxidative stress and inflammation ( 5 GLP-1 and various organs GLP-1 has been shown to carry out numerous protective and regulatory functions in different organ systems
In the brain, it activates receptors in the hypothalamus that reduce hunger and increase the feeling of fullness after eating
Semaglutide: Best overall for weight loss Why it's #1 for fat loss: FDA-approved for weight loss (Wegovy) Clinical trials show 15-20% body weight loss Reduces appetite dramatically Improves metabolic health Preserves muscle while losing fat Best for: Significant weight loss (20+ lbs) Appetite control Long-term sustainable fat loss Metabolic improvement Dosing: Start: 0.25mg weekly Titrate up slowly to 1-2.4mg weekly over 16-20 weeks Injectable subcutaneous once weekly Use until goal weight reached Timeline: Week 1-4: Appetite reduction begins Month 2-3: Noticeable weight loss (5-10 lbs) Month 4-6: Significant loss (15-25 lbs) Month 6-12: Continued loss to goal Use our semaglutide dosage calculator and see semaglutide vs tirzepatide comparison